𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Survival of patients with palliative head and neck cancer

✍ Scribed by Quirine C. P. Ledeboer; Marc P. van der Schroeff; Jean F. A. Pruyn; Maarten F. de Boer; Robert J. Baatenburg de Jong; Lilly-Ann van der Velden

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
296 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

The purpose of this study was to describe patient characteristics and prognostic factors for survival in the palliative stage of patients with head and neck cancer.

Methods

Since November 2003, all patients with palliative head and neck cancer treated in our hospital have been recorded in a central database. In total, 262 deceased patients were included in this retrospective study.

Results

The reasons for palliation were inoperability, distant metastases, refusal of curative treatment, or poor condition. The mean palliative phase lasted 5.3 months for patients with squamous cell carcinomas. Involvement of a specialized nurse was significantly related with the number of admissions and place of dying. Multivariate analysis showed comorbidity and treatment to be independent predictors of survival in the palliative phase.

Conclusion

Comorbidity and palliative interventions are possible prognostic factors for survival. The involvement of a specialized nurse might be associated with an improved quality of life. Β© 2010 Wiley Periodicals, Inc. Head Neck, 2011

πŸ“œ SIMILAR VOLUMES

Prediction of survival in patients with
Prediction of survival in patients with head and neck cancer
✍ Robert Jan Baatenburg de Jong; Jo Hermans; Jan Molenaar; Jeroen Johannes Briaire πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 363 KB πŸ‘ 2 views

## Background: In patients with head and neck squamous cell carcinoma (hnscc) the estimated prognosis is usually based on the tnm classification. the relative weight of the three contributing parameters is often not completely clear. moreover, the impact of other important clinical variables such a

Methylphenidate treatment of patients wi
Methylphenidate treatment of patients with head and neck cancer
✍ Fernandez, Francisco ;Adams, Frank πŸ“‚ Article πŸ“… 2006 πŸ› Wiley (John Wiley & Sons) βš– 491 KB πŸ‘ 2 views

Five organically impaired and depressed head and neck cancer patients had a marked therapeutic response to methylphenidate (MPD). There was a rapid remission of depressive and cognitive dysfunctions without adverse side effects. The relationship of cognitive, behavioral, and affective symptoms to br

Experience of palliative care for patien
Experience of palliative care for patients with head and neck cancer through the eyes of next of kin
✍ Quirine C. P. Ledeboer; Marinella P. J. Offerman; Lilly-Ann van der Velden; Maar πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 90 KB πŸ‘ 1 views

## Abstract ## Background. Little is known about how palliative care is experienced by patients with head and neck cancer and their relatives. The aim of this retrospective study was to analyze this care from the point of view of surviving relatives. ## Methods. Fifty‐five surviving relatives of

Determinants of head and neck cancer sur
Determinants of head and neck cancer survival by race
✍ Camille C. Ragin; Scott M. Langevin; Mark Marzouk; Jennifer Grandis; Emanuela Ta πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 110 KB

## Abstract ## Background Several factors contribute to the documented racial disparity in head and neck cancer, among which are socioeconomic status, access to care, and biologic factors. ## Methods Clinical characteristics of 87 African‐American patients with head and neck cancer and a random

Mechanisms of hypercalcemia in patients
Mechanisms of hypercalcemia in patients with head and neck cancer
✍ Angel, Michael F. ;Stewart, Andrew ;Pensak, Myles L. ;Pillsbury, Harold R. C. ;S πŸ“‚ Article πŸ“… 1982 πŸ› Wiley (John Wiley & Sons) βš– 491 KB πŸ‘ 2 views

## Abstract Hypercalcemia associated with head and neck malignancy is not an uncommon occurrence; its causes are multiple. Eight hypercalcemic patients with head and neck malignancy were studied. Serum calcium, serum phosphorus, tubular phosphorus threshold, fasting calcium excretion, plasma 1,25‐d